08-02-2017 дата публикации
Номер: KR1020170014835A
Принадлежит:
The present invention relates to a method for predicting a risk of developing colorectal cancer, by observing a specific single nucleotide polymorphism (SNP) base which is significantly correlated with the risk of developing colorectal cancer. The present invention further relates to a composition for predicting the risk of developing colorectal cancer, containing cDNA or a polynucleotide for checking the SNP, and to a kit and a microarray including the cDNA and the polynucleotide. COPYRIGHT KIPO 2017 (A1,A2,A3,A4,A5,A6,A7,A8,A9,A10,A11,A12,A13,A14,A15,A16,A17,A18,A19,A20,A21,A22) Untreated group (B1,B2,B3,B4,B5,B6,B7,B8,B9,B10,B11,B12,B13,B14,B15,B16,B17,B18,B19,B20,B21,B22) Control group (C1,C2,C3,C4,C5,C6,C7,C8,C9,C10) miR-3614-5p-treated group (DD) Expression level of SLC13A3 after treating each allelotype of rs8149 with hsa-miR-3614-5p (EE) Expression level of TOMM20 after treating each allelotype of rs7930 with hsa-miR-4273 (F1,F2,F3,F4,F5,F6,F7,F8,F9,F10,F11,F12) miR-4273-treated ...
Подробнее